Pharmaceutical News

RSS

Brazilian investigators call for targeted interventions among young crack users

A Brazilian investigative team, collaborating with a Simon Fraser University researcher, is citing an urgent need for targeted interventions among young crack users in cities throughout Brazil, identified as the world's biggest crack market, and further research to better address the problem.

15 May 2013

Magic bullet nanomedicine offers potential treatment option for Acute Lung Injury

Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.

15 May 2013

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.

15 May 2013

Novel drug may increase the effectiveness of radiation therapy for brain cancer

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.

15 May 2013

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Sigma-Tau Pharmaceuticals, Inc. announced today that the Company was recognized last evening as a rare disease pioneer at the 30th anniversary celebration of The National Organization for Rare Disorders.

15 May 2013

Obama administration asks appeals court to delay judge's order on emergency contraceptive

The federal government's legal fight over the availability of emergency contraception is heating up at the next level in the courts.

15 May 2013

Subsidiary of Indian drug firm pleads guilty, agrees to $500 million penalty

A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.

15 May 2013

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage).

15 May 2013

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

14 May 2013

CMC Biologics, RuiYi to develop a cell line for RYI-008

CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.

14 May 2013

Renaissance in drug development for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.

14 May 2013

Neutra in final stages of negotiations toward new partnership in U.S. MMJ industry

Neutra Corp., a growing provider of all-natural wellness solutions, announced today that it has entered the final stages of negotiations toward a potentially lucrative new partnership in the $1.7 billion U.S. medical marijuana industry.

14 May 2013

Medicare lags in detecting hazardous prescribing patterns

An analysis by ProPublica and The Washington Post has found that Medicare does little to track doctor prescription patterns when they're prescribing potentially hazardous drugs.

14 May 2013

Research findings may pave way to new treatment for Alzheimer's disease in humans

A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.

14 May 2013

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved its New Drug Application for Nymalize (nimodipine) oral solution.

14 May 2013

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

A large-scale National Eye Institute study has shown fish oil supplements containing omega-3 fatty acids do not alter the progression of age-related macular degeneration, says a national team of researchers including David M. Brown, M.D., an retina specialist at The Methodist Hospital who ran Houston's part of the study.

14 May 2013

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found a combination of drugs to potentially treat chronic lymphocytic leukemia more effectively.

14 May 2013

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

Some parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.

14 May 2013

FDA grants priority review for Janssen's simeprevir

Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

14 May 2013

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Biogen Idec announced today that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for the marketing approval of ELOCTATE (recombinant factor VIII Fc fusion protein) for the treatment of hemophilia A.

13 May 2013

Pharmaceutical News

Brazilian investigators call for targeted interventions among young crack users

Magic bullet nanomedicine offers potential treatment option for Acute Lung Injury

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Obama administration asks appeals court to delay judge's order on emergency contraceptive

Subsidiary of Indian drug firm pleads guilty, agrees to $500 million penalty

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

CMC Biologics, RuiYi to develop a cell line for RYI-008

Renaissance in drug development for rare diseases

Neutra in final stages of negotiations toward new partnership in U.S. MMJ industry

Medicare lags in detecting hazardous prescribing patterns

Research findings may pave way to new treatment for Alzheimer's disease in humans

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Fish oil supplements may not alter progression of age-related macular degeneration, say researchers

NCCC doctors find effective drug combination to treat chronic lymphocytic leukemia

Tel Aviv University researchers invent a method for repairing damaged peripheral nerves

FDA grants priority review for Janssen's simeprevir

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News